Latest Asx News

Kingsgate Consolidated sustained robust production at Chatree with a fifth straight quarter exceeding 20,000 ounces of gold, while achieving a record AISC margin and boosting cash reserves to A$213 million.

Resolution Minerals is set to kick off a major 13,700-metre diamond drilling program at its Golden Gate project in Idaho, aiming to expand gold discoveries and delineate tungsten mineralisation near historical workings.

Green & Gold Minerals completed the Herberton Conductor Metals Project acquisition, unveiling high-grade copper, silver, indium, and rare earth discoveries while maintaining a strong cash position for 2026 exploration.

Asara Resources has reported robust drilling results at its flagship Kada Gold Project in Guinea, confirming extensions to mineralisation and expanding the resource footprint. The company is also progressing regional exploration and advancing a key acquisition, maintaining a solid cash position to fund ongoing work.

Alexium International Group has boosted sales to $1.03 million following its Microtek Laboratories acquisition, shifting focus to manufacturing-led growth and expanding its flame-retardant and thermal regulation product lines.

Regis Healthcare expects FY26 underlying EBITDA of approximately $135 million, buoyed by near-record occupancy and a disciplined capital strategy amid evolving government reforms.

Rimfire Pacific Mining has boosted its Murga Scandium Deposit resource by 300% to 56.1Mt at 138ppm Sc, expanding its global scandium inventory to 10.6Kt Sc. The company also secured full ownership of the Rabbit Trap Scandium Project and confirmed historic gold-antimony mineralisation at Broken Hill.

Artrya has fully integrated its Salix platform at Tanner Health, is preparing two more US sites for launch, and is finalising FDA submission for its Coronary Flow module, backed by a strong cash position of $76.6 million.

Orthocell has initiated commercial sales of its Remplir nerve repair device in Canada, leveraging a distributor-led model to penetrate a US$75 million market and setting the stage for broader North American expansion.

Delorean Corporation reported solid progress in Q3 FY2026, including a positive Final Investment Decision for its NSW1 Horsley Park bioenergy facility backed by $30.5 million in grants, alongside ongoing construction at its flagship SA1 Salisbury project.

Dimerix has completed adult patient recruitment in its Phase 3 ACTION3 trial for DMX-200, with a blinded review confirming the study remains statistically powered to demonstrate treatment efficacy. The company also appointed a new CFO and is negotiating up to US$50 million in non-dilutive funding.

Godolphin Resources has raised A$2.5 million through a discounted share placement to fund a 2,500m diamond drilling program and metallurgical test work at its Lewis Ponds project, aiming to expand its JORC resource and advance development.